World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 21 January 2013
Main ID:  NCT00586534
Date of registration: 21/12/2007
Primary sponsor: Duke University
Public title: Developing Computer Based Treatments for Addiction
Scientific title: Developing Computer Based Treatments for Addiction
Date of first enrolment: January 2007
Target sample size: 180
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT00586534
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment  
Countries of recruitment
United States
Contacts
Name:   Sherika Oliver, BA
Address: 
Telephone: 919-684-1131
Email: sherika.oliver@duke.edu
Affiliation: 
Name:   Sherika Oliver, BA
Address: 
Telephone: 919-684-1131
Email: sherika.oliver@duke.edu
Affiliation: 
Name:   Zachary Rosenthal, PhD
Address: 
Telephone:
Email:
Affiliation:  Duke University
Key inclusion & exclusion criteria

Inclusion Criteria:

- Meets SCID-I criteria for cocaine dependence; crack cocaine is primary substance of
abuse

- Consents to outpatient treatment for drug addiction.

Exclusion Criteria:

- Full criteria met for psychosis

- IQ less than 70

- Unable to give consent

- Can not read

- Current and chronic absence of shelter

- Impending jail/prison for more than three weeks (problems which by their presence or
severity preclude ability to attend or understand treatment and/or requires priority
treatment over substance use treatment)

- Court order to treatment or to jail, or agency order to treatment or loss of child
custody (due to inability to freely drop-out of treatment)

- Refuses to discontinue current drug abuse treatment or refuses random assignment



Age minimum: 18 Years
Age maximum: 60 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Cocaine Addiction
Intervention(s)
Behavioral: I/GDC
Behavioral: I/GDC + VR/CER
Primary Outcome(s)
Urinalyses [Time Frame: 1 year]
Secondary Outcome(s)
HIV Risk Behaviors [Time Frame: 6 months, 9 months, 12 months]
Interview measures: Structured Clinical Interview for DSM-IV, Axis I (SCID-I), Addiction Severity Index [Time Frame: Intake, 6 month, 9 month, and 12 month assessments.]
Physiological measures: skin conductance, heart rate, and skin temperature [Time Frame: Intake, 6 month, 9 month, and 12 month follow-up assessments]
Self-report measures of Substance use [e.g., TLFB; Minnesota Cocaine Craving Questionnaire (MCCS); Cocaine Craving Questionnaire (CCQ)] [Time Frame: Intake assessment, 6 months, 9months, 12 months]
Secondary ID(s)
Pro00011048
R01DA026454
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
National Institute on Drug Abuse (NIDA)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history